MentionFoxThetis Pharmaceuticals LLC filed a Form D with the Securities and Exchange Commission on 2026-10-13.
Thetis Pharmaceuticals LLC filed a Form D notice of an exempt securities offering with the SEC on October 13, 2026. The filing reports $560K sold. Its industry group is Pharmaceuticals. It names Gary Mathias (Manager), Walter Ogier (Manager), Frank Sciavolino (Manager) (SEC Form D, October 13, 2026).
Sell to companies like Thetis Pharmaceuticals LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-10-13 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Thetis Pharmaceuticals LLC.
Free to see. No signup.
We'll show it in your MentionFox inbox when Thetis Pharmaceuticals LLC raises, hires or launches. No email unless you switch it on.
Watch Thetis Pharmaceuticals LLC →Get the full cited report on Thetis Pharmaceuticals LLC
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Thetis Pharmaceuticals LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Thetis Pharmaceuticals LLC See pricing
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $560K, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
Thetis Pharmaceuticals develops TP-317, a first-in-class oral BLT1 agonist based on Resolvin E1 for inflammatory bowel disease and solid tumor cancers.
The title and description the site itself served, answering 200, after redirecting from https://thetispharma.com. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Gary Mathias is named as Manager on the Form D that Thetis Pharmaceuticals LLC filed with the SEC on 13 October 2026, one of 6 people that filing names.
On the filing as: Director.
Walter Ogier is named as Manager on the Form D that Thetis Pharmaceuticals LLC filed with the SEC on 13 October 2026, one of 6 people that filing names.
On the filing as: Director.
Frank Sciavolino is named as Manager on the Form D that Thetis Pharmaceuticals LLC filed with the SEC on 13 October 2026, one of 6 people that filing names.
On the filing as: Director.
Dennis Willson is named as Manager on the Form D that Thetis Pharmaceuticals LLC filed with the SEC on 13 October 2026, one of 6 people that filing names.
On the filing as: Director.
Fabio Cataldi is named as Manager on the Form D that Thetis Pharmaceuticals LLC filed with the SEC on 13 October 2026, one of 6 people that filing names.
On the filing as: Director.
David Cook is named as Manager on the Form D that Thetis Pharmaceuticals LLC filed with the SEC on 13 October 2026, one of 6 people that filing names.
6 people named on the filing — 1 holding an executive role and 5 as directors only.
Named as of the 2026-10-13 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Thetis Pharmaceuticals LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Thetis Pharmaceuticals LLC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Thetis Pharmaceuticals LLCYou get an alert in MentionFox the next time this company shows up.
If you're behind Thetis Pharmaceuticals LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-10-16 (thetispharma.com).
Each opens in a new tab, filled in for Thetis Pharmaceuticals LLC. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/thetis-pharmaceuticals-llc-form-d-000003